Welcome to SYNHEALTH

Leveraging glycan biomarkers for personalized
and preventive healthcare

About us

About SynHealth

Funded by the Horizon Europe Programme, SynHealth is an innovative project set to reshape preventive healthcare by transitioning from traditional remedial care to personalized medicine.
 
By leveraging 15 years of pioneering Genos research on glycan biomarkers and past EU-funded initiatives, the project focuses on the valorisation of these discoveries for real-world application in Croatia and Slovenia. Through regional partnerships and technology transfer, SynHealth aims to translate research breakthroughs into clinical diagnostic tools for healthy longevity.

Our Objectives

Develop person-centred AI based support tool to enable scalability of GlycanAge personalised counselling

Demonstrate adoption of glycan biomarkers for personalised preventive healthcare in real world setting and create a network of partners in the region

Prepare clinical study for glycan biomarkers for personalised preventive medicine

Improve capacity for innovation, IP management and knowledge transfer

Maximise the impact of the project through a dedicated communication, dissemination and exploitation strategy

SYNHEALTH in numbers

Estimated Cost
0 M
Months
0
Beneficiaries
0
Countries involved
0
Organisations
0

(3 Research centres, 2 Universities and 1 SME)

Latest News

Partners

Subscribe to our newsletter

Join the SYNHEALTH community and get the latest news on glycan biomarkers, AI-driven solutions, and the future of preventative healthcare